Medical Weight Loss for Oak Lawn, Illinois Residents
Oak Lawn, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Oak Lawn through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Oak Lawn Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Oak Lawn, Illinois residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
From our Costa Mesa, California practice, we provide Oak Lawn with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
Patients across Oak Lawn and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Illinois. We care for patients throughout downtown Oak Lawn and the southwest Chicago suburbs of Cook County. Compounded semaglutide and tirzepatide ship directly to your door in Illinois, and a licensed physician reviews every plan before anything is prescribed.
Our telehealth model serves Oak Lawn and communities across Illinois with the same flat pricing and the same supervising physician. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Oak Lawn patients.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Oak Lawn patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Oak Lawn
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Oak Lawn address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Oak Lawn
Does New Hope Weight Loss treat patients in Oak Lawn?
Yes. Although the clinic is in Costa Mesa, California, we treat Oak Lawn, Illinois residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Oak Lawn?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Oak Lawn address in cold-pack packaging.
What do Oak Lawn patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Oak Lawn do you serve?
We serve patients from across Oak Lawn by telehealth, including downtown Oak Lawn and the southwest Chicago suburbs of Cook County.
Who qualifies for the program in Oak Lawn?
Eligibility for Oak Lawn patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Oak Lawn, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.